B53.0 Plasmodium ovale malaria

Name of the Condition

• Plasmodium ovale malaria

Summary

Plasmodium ovale malaria is a parasitic infection caused by Plasmodium ovale, a species of malaria parasite. The condition is characterized by fever, chills, and other systemic symptoms, with severity influenced by factors such as host immunity and treatment response. Unlike some other malaria types, P. ovale infections may have a delayed relapse pattern due to hypnozoites (dormant liver stages).

Causes

The condition is caused by infection with Plasmodium ovale parasites, transmitted through the bite of infected Anopheles mosquitoes. The parasites invade red blood cells, leading to cyclical symptoms and potential complications. Transmission occurs in regions where P. ovale is endemic, primarily in parts of sub-Saharan Africa and the western Pacific.

Risk Factors

• Residence in or travel to malaria-endemic regions where P. ovale is prevalent.
• Lack of prophylactic antimalarial medication during exposure.
• Immunocompromised states (e.g., HIV, chemotherapy) reducing resistance.
• Pregnancy, increasing severity and fetal risk.
• Previous malaria infection with incomplete immunity.

Symptoms

• Recurrent fever, chills, and sweats (classic paroxysmal cycles).
• Headache, muscle pain, and fatigue.
• Nausea, vomiting, or diarrhea.
• Jaundice or dark urine in severe cases.
• Anemia or splenomegaly with prolonged infection.

Diagnosis

Diagnosis involves identifying Plasmodium ovale parasites in blood samples, typically via microscopy or rapid diagnostic tests. Clinical evaluation includes assessing symptoms, travel history, and exposure risk. Confirmatory testing may include molecular methods (e.g., PCR) to distinguish P. ovale from other malaria species.

Treatment Options

Treatment generally includes antimalarial medications such as chloroquine or artemisinin-based combinations, followed by primaquine to target hypnozoites and prevent relapses. Therapy is tailored to the patient’s age, severity, and regional resistance patterns. Supportive care may address symptoms like fever or dehydration.

Prognosis and Follow-Up

With prompt and appropriate treatment, prognosis is generally good, though relapses can occur due to hypnozoites. Follow-up may involve monitoring for recurrence, especially in the months after initial treatment. Severe cases or complications (e.g., anemia, organ dysfunction) may require extended care.

Complications

• Severe anemia from red blood cell destruction.
• Cerebral malaria or other organ dysfunction in rare cases.
• Relapses due to dormant liver stages (hypnozoites).
• Increased risk of severe disease in pregnant individuals or immunocompromised patients.

Lifestyle & Prevention

• Use insect repellent and bed nets in endemic areas.
• Take prophylactic antimalarials as prescribed for travel.
• Seek prompt medical care for fever after potential exposure.
• Avoid mosquito bites through protective clothing and screened environments.

When to Seek Professional Help

Seek immediate medical attention for fever, chills, or flu-like symptoms after travel to malaria-endemic regions. Urgent care is needed for severe symptoms (e.g., confusion, jaundice, difficulty breathing) or if symptoms persist despite treatment.

Tips for Medical Coders

Document the diagnosis of Plasmodium ovale malaria with code B53.0. Ensure clinical documentation supports the specific parasite identification, as this code is distinct from other malaria types. Note any relapses or treatment courses, as these may impact coding accuracy.